期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

2型糖尿病的循证治疗 被引量：3

Evidence-Based Treatment for Type 2 Diabetes Mellitus
下载PDF
导出
摘要 以Meta 分析和随机对照试验文献为基础 ,回顾近年来用于 2型糖尿病血糖控制的药物治疗及与衰老相关的糖尿病问题的循证证据。结果发现 ,胰岛素联合口服降糖药的治疗方案更能改善 2型糖尿病患者的胰岛素抵抗和胰岛 β细胞功能缺陷 ;应警惕老年 2型糖尿病患者合并的认知功能障碍和抑郁症。 Based on literatures on Meta-analysis and randomized controlled trial, drug use and some geriatrics syndromes such as cognitive impairment and depression, in elderly diabetic patients were reviewed. Insulin plus oral hypoglycemic drugs was more rational therapy for insulin resistance and islet dysfunction in type 2 diabetes mellitus. We should pay more attention to cognitive impairment and depression in elderly type 2 diabetic patients.
作者 王双
机构地区 四川大学华西医院老年科
出处 《中国循证医学杂志》 CSCD 2004年第5期346-350,354,共6页 Chinese Journal of Evidence-based Medicine
关键词 2型糖尿病 药物治疗 糖化血红蛋白 META-分析 随机对照试验 认知功能障碍 抑郁症 Type 2 diabetes mellitus Pharmacological therapy HbA1c Meta-analysis Randomized controlled trial Cognitive impairment Depression
分类号 R4 [医药卫生—临床医学] R587.105 [医药卫生—内分泌]
  • 相关文献

参考文献36

  • 1United Kingdom Prospective Diabetes Study 24. A 6-year,randomized, controlled trial comparing sulfonylurea, insulin,and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. UK Prospective Diabe
  • 2HortonES, ClinkingheardC, Gatlin M, Foley J, Mallows S,Shen S. Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type2 diabetes[J]. Diabetes Care, 2000; 23:1 660 -1 665
  • 3Moses R, Slobodniuk R, Boyages S, Colagiuri S, Kidson W, Carter J, Donnelly T, Moffitt P, Hopkins H. Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes [J ]. Diabetes Care,1999; 22( 1 ) :119 - 124
  • 4Einhom D, Rendell M, Rosenzweig J, Egan JW, Mathisen AL, Schneider RL, Pioglitazone 027 Study Group. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellltus: a randomized, placebocontrolled study[J]. Clin Ther
  • 5FonsecaV, RosenstockJ, Patwardhan R, Salzman A. Effect of metformin and rosiglltazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial[J]. JAMA, 2000; 283(13): 1 695-1 702
  • 6Weyer C, Tataranni PA, Bogardus C, Pratley RE. Insulin resistance and insulin secretory dysfunction are dependent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development[J ]. Diabetes Care, 2001; 24(1 ) :89 -94
  • 7Horton ES, Whitehouse F, Ghazzi MN, Venable TC, Whitcomb RW, Troglltazone Study Group. Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes [ J ]. Diabetes Care, 1998; 21: ( 9 ) 1 462- 1 469.
  • 8Kipnes MS, Krosnick A, Rendell MS, Egan JW, Mathisen AL, Schneider RL. Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitns: a randomized, placebocontrolled study[J]. Am J
  • 9Willms B, Ruge D. Comparison of acarbose and metformin in patients with type 2 diabetes mellitus insufficiently controlled with diet and sulphonylureas: a randomized, placebo Vcontrolled study [ published correction appears in Diabet Med,2000;17(4) :332]
  • 10Massi BM, Humburg E, Dressler A, Ziemen M. A one-year,randomised, multicentre trial comparing insulin glargine with NPH insulin in combination with oral agents in patients with type2 diabetes[J]. Horm Metab Res, 2003; 35(3) :189 -196

同被引文献9

引证文献3

二级引证文献11

中国循证医学杂志
2004年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部